Physician profile
John J Larkin
NPI 1871598664
$2,141.89
in general payments reported to CMS, 2019-2025
21 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $115 · 2021: $441 · 2022: $522 · 2023: $354 · 2024: $215 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $627.90 | 2021-2024 | Persona |
| Pacira Pharmaceuticals Incorporated | $212.78 | 2022-2025 | Exparel, Zilretta, Iovera |
| Linvatec Corporation | $156.38 | 2023 | Linvatec Shoulder Arthroscopy, Linvatec Hip Preservation System, Livatec Knee Preservation System |
| Pacira Therapeutics, INC. | $148.39 | 2019-2021 | |
| Stryker Corporation | $143.37 | 2021-2023 | Mistral-Air, Iconix, Blueprint Patient Specific Instrumentation |
| Miach Orthopaedics, INC. | $135.19 | 2023 | |
| Ferring Pharmaceuticals INC. | $115.22 | 2019-2022 | |
| Ucb, INC. | $89.11 | 2019-2020 | |
| Depuy Synthes Sales INC. | $77.51 | 2024-2025 | Orthovisc, Monovisc |
| Kowa Pharmaceuticals America, INC. | $70.06 | 2022 | |
| Conformis, INC. | $69.08 | 2019 | |
| Smith+Nephew, INC. | $50.64 | 2019 | |
| Forte Bio-Pharma LLC | $47.58 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Curonix LLC | $43.33 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Solventum Corporation | $33.35 | 2025 | Activ.A.C., V.A.C.Instill, Prevena |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.59 | 2022 | |
| Horizon Therapeutics Plc | $26.54 | 2020-2022 | |
| Vericel Corporation | $19.94 | 2024 | Maci |
| Reprise Biomedical, INC. | $18.67 | 2024 | Miro3d |
| Orthofix Medical, INC. | $15.30 | 2025 | Accelstim |
| Avanos Medical | $14.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Larkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.